Hollencrest Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$40.5K Hold
2025
Q2
$30.4K Hold
2025
Q1
$21.3K Hold
2024
Q4
$24.6K Hold
2024
Q3
$29.4K Hold
2024
Q2
$33.8K Hold
2024
Q1
$42.6K Hold
2023
Q4
$39.1K Hold
2023
Q3
$28.4K Hold
2023
Q2
$35.1K Hold
2023
Q1
$28.3K Hold
2022
Q4
$25.4K Buy